Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie
About Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
CENTOGENE GmbH Rostock
2
Jena University Hospital
2
Biogen
1
D-Pharm Ltd.
1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
1
NoNO Inc.
1
University Hospital Tuebingen
1
Clinical Trials at Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie
During the past decade, Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke
2005-02-01
2006-10-01
Completed
150
Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation
2007-07-01
2019-12-01
Completed
100
Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients
2008-01-01
2010-01-01
Completed
5,000
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis
2020-05-13
2024-10-31
Recruiting
50
Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis
2020-12-06
2024-02-01
Active, not recruiting
850
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "CENTOGENE GmbH Rostock" with 2 trials
sponsored, "Jena University Hospital" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "D-Pharm Ltd."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie"
#1 collaborator was "Shire Human Genetic Therapies, Inc." with 2 trials as a collaborator, "Center for Sepsis Control and Care, Germany" with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "Instituto Grifols, S.A." with 1 trials as a collaborator and "SepNet - Critical Care Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" are
"Multiple Sclerosis" (3 trials), "Cerebrovascular Accident" (2 trials), "Autoimmune Encephalitis" (1 trials), "Brain Ischemia" (1 trials) and "Cerebrovascular Disorders" (1 trials). Many other conditions were trialed in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie
Most popular intervention types in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" are "Drug" (8 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (3 trials), "Placebo" (3 trials), "Antihistamine" (2 trials), "Methylprednisolone" (2 trials) and "No intervention" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie
The vast majority of trials in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" are
12 trials for "All" genders.
Clinical Trials Status at Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie
Currently, there are NaN active trials in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie".
1 are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".